Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.

Leukemia - 1 Apr 2010

Kobayashi T, Kuroda J, Ashihara E, Oomizu S, Terui Y, Taniyama A, Adachi S, Takagi T, Yamamoto M, Sasaki N, Horiike S, Hatake K, Yamauchi A, Hirashima M, Taniwaki M

Abstract excerpt

Galectins constitute a family of lectins that specifically exhibit the affinity for beta-galactosides and modulate various biological events. Galectin-9 is a tandem-repeat type galectin with two carbohydrate recognition domains and has recently been shown to have an anti-proliferative effect on c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Boronic Acids
Share to Bortezomib
Share to Galectins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to JNK Mitogen-Activated Protein Kinases

Share to MAP Kinase Kinase Kinases

Share to Multiple Myeloma

Share to Pyrazines

Share to Whole-Body Irradiation

Source

Identifiers

PMID: 20200560
DOI: 10.1038/leu.2010.25

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20200560-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.PMID 20200560Read ↗

Galectin-9 – ligand axis: an emerging therapeutic target for multiple myelomaSemantic proximity Read ↗

Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous LeukemiaSemantic proximity Read ↗

Roles of Galectin-7 in CancerSemantic proximity Read ↗

p38 MAPK Molecular Targeting for Next-Generation Multiple Myeloma TherapySemantic proximity Read ↗

Galectins as Cancer BiomarkersSemantic proximity Read ↗

A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myelomaSemantic proximity Read ↗

Influence of Galectin-9 Treatment on the Phenotype and Function of NK-92MI Cells in the Presence of Different Serum Supplements.Semantic proximity Read ↗

LGR4 promotes proliferation and homing via activation of the NF‑κB signaling pathway in multiple myelomaSemantic proximity Read ↗

Extracellular galectins as controllers of cytokines in hematological cancerSemantic proximity Read ↗

Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cellsSemantic proximity Read ↗

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γSemantic proximity Read ↗

Galectin-9 signaling drives breast cancer invasion through matrixSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.